TW200420294A - Methods of making and using theaflavin, thealflavin-3-gallate, theaflavin-3'-gallate and theaflavin 3, 3'-digallate and mixtures thereof - Google Patents

Methods of making and using theaflavin, thealflavin-3-gallate, theaflavin-3'-gallate and theaflavin 3, 3'-digallate and mixtures thereof

Info

Publication number
TW200420294A
TW200420294A TW091134593A TW91134593A TW200420294A TW 200420294 A TW200420294 A TW 200420294A TW 091134593 A TW091134593 A TW 091134593A TW 91134593 A TW91134593 A TW 91134593A TW 200420294 A TW200420294 A TW 200420294A
Authority
TW
Taiwan
Prior art keywords
theaflavin
gallate
methods
digallate
making
Prior art date
Application number
TW091134593A
Other languages
Chinese (zh)
Inventor
Jian Zhao
Rui Zhou
Hu Chen
Original Assignee
Nashai Biotech Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=29256809&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TW200420294(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nashai Biotech Llc filed Critical Nashai Biotech Llc
Publication of TW200420294A publication Critical patent/TW200420294A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention discloses methods of making a mixture of theaflavin, theaflavin-3-gallate, theaflavin-3'-gallate and theaflavin 3, 3'-digallate, pharmaceutical compositions of the above mixture of theaflavins, diet supplement compositions of the above mixture of theaflavins and methods for using the above mixtures of theaflavin and pharmaceutical compositions thereof to treat or prevent various diseases. The present invention also discloses methods of making theaflavin, theaflavin-3-gallate, theaflavin-3'-gallate and theaflavin 3, 3'-digallate, each as a separate compound, pharmaceutical compositions of the above compounds, diet supplement compositions of the above compounds and methods for using the above compounds to treat or prevent various diseases.
TW091134593A 2001-11-28 2002-11-27 Methods of making and using theaflavin, thealflavin-3-gallate, theaflavin-3'-gallate and theaflavin 3, 3'-digallate and mixtures thereof TW200420294A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US33351501P 2001-11-28 2001-11-28
CNB021115125A CN1156276C (en) 2002-04-26 2002-04-26 New use of theaflavin
US41357602P 2002-09-24 2002-09-24

Publications (1)

Publication Number Publication Date
TW200420294A true TW200420294A (en) 2004-10-16

Family

ID=29256809

Family Applications (1)

Application Number Title Priority Date Filing Date
TW091134593A TW200420294A (en) 2001-11-28 2002-11-27 Methods of making and using theaflavin, thealflavin-3-gallate, theaflavin-3'-gallate and theaflavin 3, 3'-digallate and mixtures thereof

Country Status (3)

Country Link
KR (1) KR100855526B1 (en)
CN (1) CN1156276C (en)
TW (1) TW200420294A (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101081844B (en) * 2006-06-01 2011-08-17 北京工商大学 Method for large-batch separating preparation of high-purity theaflavine monomer
CN102366094A (en) * 2011-09-22 2012-03-07 唐传生物科技（厦门）有限公司 Fat-reducing and hypolipemic health food
WO2015198614A1 (en) * 2014-06-27 2015-12-30 株式会社Ｎｂｃメッシュテック Catalyst for synthesizing theaflavin and method for synthesizing theaflavin
CN105250261A (en) * 2015-11-19 2016-01-20 成都普瑞法科技开发有限公司 Theaflavin-containing pharmaceutical composition and application thereof in the aspect of lowering blood fat
CN107280001A (en) * 2016-04-05 2017-10-24 上海茶宝贸易有限公司 A kind of blood lipid-reducing blood sugar-decreasing composition, composite sweetener and preparation method, application
CN108294309A (en) * 2017-01-13 2018-07-20 上海科宝生物技术有限公司 Black tea extract and preparation method thereof
CN106810381A (en) * 2017-03-27 2017-06-09 陈键 A kind of fern fiber crops special fertilizer and preparation method thereof
CN108685855A (en) * 2018-07-13 2018-10-23 安徽亳药千草国药股份有限公司 A kind of preparation method of annular effervescent with health role
KR102359446B1 (en) * 2019-04-25 2022-02-09 (주)아모레퍼시픽 Composition comprising theaflavin for promoting differentiation of adipocyte
CN111821294B (en) * 2020-04-30 2022-04-15 牡丹江医学院 Medicine with neuroprotective effect and application thereof

Also Published As

Publication number Publication date
CN1156276C (en) 2004-07-07
KR20040081428A (en) 2004-09-21
KR100855526B1 (en) 2008-09-01
CN1452961A (en) 2003-11-05

Similar Documents

Publication Publication Date Title
WO2004112715A3 (en) Methods of making and using theaflavin,theaflavin-3-gallate, theaflavin-3’-gallate and theaflavin 3,3’ - digallate and mixtures thereof
EP1460999A4 (en) Methods of making and using theaflavin, theaflavin-3-gallate, theaflavin-3'-gallate and theaflavin 3,3'-digallate and mixtures thereof
BG103740A (en) Phytostyrene composition for the prevention of the alzheimer's disease
IL127244A (en) Substituted amines, methods of their preparation and pharmaceutical compositions containing them
MY129512A (en) Novel medicament compositions, based on tiotropium bromide and salmeterol
OA09772A (en) "mometasone furoate monohydrate, process for making same and pharmaceutical compositions".
BG103870A (en) Substituted benzopyran derivatives for the treatment of inflammations
WO2000021910A3 (en) 1,2-disubstituted cyclopropanes
EP0807633A3 (en) Novel 2,3-disubstituted-(5,6)- heteroarylfused-pyrimidine-4-ones
EP1466898A4 (en) Beta-amyloid protein production/secretion inhibitors
TW200420294A (en) Methods of making and using theaflavin, thealflavin-3-gallate, theaflavin-3'-gallate and theaflavin 3, 3'-digallate and mixtures thereof
PL309282A1 (en) Application of 2-amino-6-n-propyl-amino- 4,5,6,7-tetrahydrobenzothiasole (pramipexol) as an antidepressant
WO2002039956A3 (en) Black tea extract for prevention of disease
BG105197A (en) Polymorph form of a medicament
EP0604354A3 (en) Antidepressant and antiparkinsonian compounds.
MXPA03004672A (en) Substituted 4,5-dihydro-1,2,4-triazin-6-ones, 1,2,4-triazin-6-ones, and their use as fungicides and insecticides.
CA2264005A1 (en) Piperazino derivatives as neurokinin antagonists
CA2218887A1 (en) Piperazino derivatives as neurokinin antagonists
MX337902B (en) Methods of making and using theaflavin, theaflavin-3-gallate, theaflavin-3'-gallate and theaflavin 3,3'-digallate and mixtures thereof.
WO2004048381A3 (en) Pyrazoloazepine compounds as pharmaceutical agents
TW325472B (en) A pharmaceutical composition for preventing cancer comprising 2-(1-hydroxyethyl)-5-hydroxynaphto[2,3-b]furan-4,9-dione
BG103986A (en) Derivatives of pyrrolidinecarboxylic acids as endotheline antagonists
PL361936A1 (en) Substituted 4,5-dihydro-1,2,4-triazin-3-ones, 1,2,4-triazin-3-ones, and their use as fungicides and insecticides
RO115414B1 (en) Intranasal pharmaceutical composition
WO2000037465A3 (en) Novel derivatives of swainsonine, processes for their preparation, and their use as therapeutic agents